Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: a single institution experience.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples